Zenas BioPharma (ZBIO) News Today $23.90 -1.11 (-4.44%) As of 10/24/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZBIO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Zenas BioPharma files to sell 6.31M shares of common stock for holdersOctober 21, 2025 | msn.comInsiders Bet Big on These 3 Fintech and Biotech StocksOctober 17, 2025 | 247wallst.comZenas BioPharma (NASDAQ:ZBIO) Hits New 52-Week High - Still a Buy?October 16, 2025 | marketbeat.comNunn Jason Raleigh buys Zenas Biopharma (ZBIO) shares worth $1.2 millionOctober 16, 2025 | investing.comJason Raleigh Nunn Acquires 63,158 Shares of Zenas BioPharma (NASDAQ:ZBIO) StockOctober 15, 2025 | marketbeat.comSr One Capital Management, Llc Acquires 126,315 Shares of Zenas BioPharma (NASDAQ:ZBIO) StockOctober 15, 2025 | marketbeat.comZenas BioPharma (NASDAQ:ZBIO) Director Purchases $1,200,002.00 in StockOctober 15, 2025 | insidertrades.comSr One Capital buys Zenas Biopharma (ZBIO) shares worth $2.4 millionOctober 15, 2025 | investing.comEnright buys Zenas Biopharma (ZBIO) stock worth $2.25 millionOctober 14, 2025 | investing.comPatrick Enright Buys 105,265 Shares of Zenas BioPharma (NASDAQ:ZBIO) StockOctober 14, 2025 | marketbeat.comQ3 Earnings Estimate for Zenas BioPharma Issued By WedbushOctober 13, 2025 | marketbeat.comZenas BioPharma (ZBIO) Is Up 32.5% After Securing Global Rights to Orelabrutinib in MS DealOctober 10, 2025 | finance.yahoo.comInsider Buying: Zenas BioPharma (NASDAQ:ZBIO) Insider Buys 36,928 Shares of StockOctober 10, 2025 | marketbeat.comHongbo Lu Acquires 58,823 Shares of Zenas BioPharma (NASDAQ:ZBIO) StockOctober 10, 2025 | marketbeat.comZenas BioPharma (NASDAQ:ZBIO) Director Hongbo Lu Purchases 263,160 SharesOctober 10, 2025 | marketbeat.comFairmount Funds Management Llc Acquires 316,219 Shares of Zenas BioPharma (NASDAQ:ZBIO) StockOctober 10, 2025 | marketbeat.comZenas BioPharma (NASDAQ:ZBIO) Sets New 1-Year High Following Analyst UpgradeOctober 10, 2025 | marketbeat.comWedbush Issues Positive Forecast for Zenas BioPharma (NASDAQ:ZBIO) Stock PriceOctober 10, 2025 | marketbeat.comLu Hongbo buys Zenas Biopharma (ZBIO) shares worth $6mOctober 10, 2025 | investing.comWedbush Maintains Zenas BioPharma (ZBIO) Outperform RecommendationOctober 10, 2025 | msn.comHC Wainwright Reiterates Buy Rating for Zenas BioPharma (NASDAQ:ZBIO)October 10, 2025 | marketbeat.comZenas BioPharma: Strategic Licensing and Clinical Advancements Justify Buy RatingOctober 10, 2025 | tipranks.comInsider Buying: Zenas BioPharma (NASDAQ:ZBIO) Insider Acquires 36,928 Shares of StockOctober 10, 2025 | insidertrades.comHC Wainwright & Co. Reiterates Zenas BioPharma (ZBIO) Buy RecommendationOctober 9, 2025 | msn.comZenas BioPharma rises after Wedbush raises price targetOctober 9, 2025 | msn.comZenas BioPharma: Two Late-Stage Catalysts And A $2B InnoCare DealOctober 9, 2025 | seekingalpha.comStrategic Expansion and Financial Strength Bolster Zenas BioPharma’s Growth Potential: Buy Rating ReaffirmedOctober 9, 2025 | tipranks.comZenas Biopharma stock soars after securing rights to MS drug candidateOctober 8, 2025 | za.investing.comZenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase ...October 8, 2025 | finance.yahoo.comZenas Biopharma Acquires Rights to Three Autoimmune Drug Candidates from InnoCareOctober 8, 2025 | msn.comZenas climbs on licensing deal with InnoCareOctober 8, 2025 | msn.comZenas BioPharma (NASDAQ:ZBIO) Receives "Sell (D-)" Rating from Weiss RatingsOctober 8, 2025 | marketbeat.comZenas BioPharma (NASDAQ:ZBIO) Shares Gap Up - What's Next?October 8, 2025 | marketbeat.comZenas BioPharma Secures Licensing Deal with InnoCareOctober 8, 2025 | tipranks.comZenas Bio inks potential $2 billion licensing deal with China's InnoCare for autoimmune drugOctober 8, 2025 | reuters.comZenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase 3 Development for Multiple SclerosisOctober 8, 2025 | globenewswire.comZenas BioPharma (NASDAQ:ZBIO) Trading 8.9% Higher - Here's What HappenedOctober 6, 2025 | marketbeat.comZenas BioPharma (NASDAQ:ZBIO) Shares Down 5.3% - What's Next?October 2, 2025 | marketbeat.comZenas BioPharma (NASDAQ:ZBIO) Shares Up 5% - Should You Buy?September 30, 2025 | marketbeat.comBullish Zenas BioPharma Insiders Loaded Up On US$1.11m Of StockSeptember 30, 2025 | finance.yahoo.comGoldman Sachs Group Inc. Cuts Stake in Zenas BioPharma, Inc. $ZBIOSeptember 30, 2025 | marketbeat.comZenas BioPharma (NASDAQ:ZBIO) Cut to Sell at Wall Street ZenSeptember 27, 2025 | marketbeat.comZenas BioPharma (NASDAQ:ZBIO) Trading 7.4% Higher - Should You Buy?September 24, 2025 | marketbeat.comZenas BioPharma (NASDAQ:ZBIO) Shares Down 5.1% - Here's WhySeptember 17, 2025 | marketbeat.comZenas BioPharma (NASDAQ:ZBIO) Stock Price Up 5% - Time to Buy?September 14, 2025 | marketbeat.comZenas BioPharma (NASDAQ:ZBIO) Trading Down 7.1% - What's Next?September 12, 2025 | marketbeat.comNuveen LLC Buys Shares of 31,626 Zenas BioPharma, Inc. $ZBIOSeptember 8, 2025 | marketbeat.comZenas BioPharma (NASDAQ:ZBIO) Stock Rating Upgraded by Wall Street ZenSeptember 8, 2025 | marketbeat.comWedbush Has Positive Outlook of Zenas BioPharma Q3 EarningsSeptember 7, 2025 | marketbeat.comZenas BioPharma (NASDAQ:ZBIO) Trading Up 9.8% - Here's WhySeptember 4, 2025 | marketbeat.com Get Zenas BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ZBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZBIO Media Mentions By Week ZBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZBIO News Sentiment▼1.250.93▲Average Medical News Sentiment ZBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZBIO Articles This Week▼210▲ZBIO Articles Average Week Get the Latest News and Ratings for ZBIO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Zenas BioPharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies LGND News FOLD News CLDX News MNKD News BCRX News NVAX News OPK News DVAX News INVA News GERN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZBIO) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zenas BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zenas BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZBIO Stock Alerts